BTS International Advanced Pharmaceutical Sciences Journal Ethics Policy

The BTS International Advanced Pharmaceutical Sciences Journal (BTS IAPSJ) follows strict ethical standards based on COPE (Committee on Publication Ethics) and ICMJE (International Committee of Medical Journal Editors) guidelines.

All submitted manuscripts must be original, unpublished, and free from plagiarism, data fabrication, and duplicate submission. Authors are responsible for ensuring the accuracy of data, proper authorship, conflict-of-interest disclosure, and obtaining necessary ethical approvals for studies involving humans, animals, or biological materials. The journal uses a double-blind peer-review process to ensure fairness and academic integrity.

Reviewers and editors follow confidentiality, objectivity, and COPE-recommended procedures for handling ethical concerns. The journal may issue corrections or retractions when required. All ethical concerns can be reported to btsiapsj@gmail.com.

1. Authorship & Originality

• Submissions must be original, plagiarism-free, and properly cited.

• Ghostwriting, honorary authorship, and duplicate submissions are not permitted.

 2. Peer Review Integrity

• Manuscripts undergo double-blind peer review.

• Reviewers must maintain confidentiality, avoid conflicts of interest, and provide objective, timely feedback. 

3. Ethical Approvals

• Studies involving humans/animals require institutional ethics approval.

• Authors must ensure informed consent and ethical research conduct. 

4. Editorial Responsibilities

• Editorial decisions are based on quality, relevance, and originality.

• Editors must act impartially and maintain confidentiality. 

5. Conflict of Interest

• Authors, reviewers, and editors must disclose any personal or financial conflicts.

6. Data Transparency

• Authors must provide accurate data and supply raw data upon request.

• Data fabrication, falsification, or manipulation is prohibited.